Continuous usage of low doses of human leukocyte interferon with contact lenses in herpetic keratoconjunctivitis.
14 patients with primary and recurrent herpetic keratitis were treated with continuous usage of human leukocyte interferon (HLI) at low concentration using therapeutic contact lenses. All patients recovered in a medium-short time of 7 days, including some who had not benefited by previous treatments (idoxuridine, etc.). We conclude that continuous application of HLI increases its effectiveness.
D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D003261:Contact Lenses; D003320:Corneal Ulcer / Q000188:drug therapy; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000008:administration & dosage* / Q000627:therapeutic use; D007635:Keratitis, Dendritic / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D013997:Time Factors
D007370:Interferon Type I